Impact of Multiple and Long Sirolimus-Eluting Stent Implantation on 3-Year Clinical Outcomes in the j-Cypher Registry

Shinichi Shirai, Takeshi Kimura, Masakiyo Nobuyoshi, Takeshi Morimoto, Kenji Ando, Yoshimitsu Soga, Kyohei Yamaji, Katsuhiro Kondo, Koyu Sakai, Takeshi Arita, Masahiko Goya, Masashi Iwabuchi, Hiroyoshi Yokoi, Hideyuki Nosaka, Kazuaki Mitsudo

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Objectives: Our aim was to study the relationships between total stent length (TSL) and long-term clinical outcomes after sirolimus-eluting stent (SES) implantation. Background: SES compared with bare-metal stent use for long lesion treatment is associated with reduced restenosis rates. Methods: Three-year follow-up data were available for 10,773 patients (14,651 lesions) that had been treated with only SES (Cypher, Cordis Corp., Warren, New Jersey) in the j-Cypher registry. Patients and lesions were divided into quartile groups: TSL per patient (Q1: 8 to 23 mm, Q2: 24 to 36 mm, Q3: 37 to 54 mm, Q4: 55 to 293 mm), and TSL per lesion (QA: 8 to 18 mm, QB: 19 to 23 mm, QC: 24 to 33 mm, QD: 34 to 150 mm). Results: In per-lesion data, longer TSL increased target lesion revascularization (TLR) rates but did not increase stent thrombosis rates (p = 0.2324). In per-patient data, the incidences of TLR remarkably increased with increasing TSL. Incidence of composite of death and myocardial infarction also increased with increasing TSL; however, after adjustment for baseline differences, there was no statistical significance. Definite stent thrombosis rate in group Q4 was significantly higher than in other groups, both unadjusted (hazard ratio: 1.770, p = 0.0081) and adjusted (hazard ratio: 1.727, p = 0.0122) for baseline differences. Conclusions: TSL per lesion and patient had significantly impacts on TLR rates. Longer TSL per patient was associated with increased incidence of stent thrombosis through 3 years.

Original languageEnglish
Pages (from-to)180-188
Number of pages9
JournalJACC: Cardiovascular Interventions
Volume3
Issue number2
DOIs
Publication statusPublished - Feb 1 2010
Externally publishedYes

Fingerprint

Sirolimus
Stents
Registries
Thrombosis
Incidence

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Impact of Multiple and Long Sirolimus-Eluting Stent Implantation on 3-Year Clinical Outcomes in the j-Cypher Registry. / Shirai, Shinichi; Kimura, Takeshi; Nobuyoshi, Masakiyo; Morimoto, Takeshi; Ando, Kenji; Soga, Yoshimitsu; Yamaji, Kyohei; Kondo, Katsuhiro; Sakai, Koyu; Arita, Takeshi; Goya, Masahiko; Iwabuchi, Masashi; Yokoi, Hiroyoshi; Nosaka, Hideyuki; Mitsudo, Kazuaki.

In: JACC: Cardiovascular Interventions, Vol. 3, No. 2, 01.02.2010, p. 180-188.

Research output: Contribution to journalArticle

Shirai, S, Kimura, T, Nobuyoshi, M, Morimoto, T, Ando, K, Soga, Y, Yamaji, K, Kondo, K, Sakai, K, Arita, T, Goya, M, Iwabuchi, M, Yokoi, H, Nosaka, H & Mitsudo, K 2010, 'Impact of Multiple and Long Sirolimus-Eluting Stent Implantation on 3-Year Clinical Outcomes in the j-Cypher Registry', JACC: Cardiovascular Interventions, vol. 3, no. 2, pp. 180-188. https://doi.org/10.1016/j.jcin.2009.11.009
Shirai, Shinichi ; Kimura, Takeshi ; Nobuyoshi, Masakiyo ; Morimoto, Takeshi ; Ando, Kenji ; Soga, Yoshimitsu ; Yamaji, Kyohei ; Kondo, Katsuhiro ; Sakai, Koyu ; Arita, Takeshi ; Goya, Masahiko ; Iwabuchi, Masashi ; Yokoi, Hiroyoshi ; Nosaka, Hideyuki ; Mitsudo, Kazuaki. / Impact of Multiple and Long Sirolimus-Eluting Stent Implantation on 3-Year Clinical Outcomes in the j-Cypher Registry. In: JACC: Cardiovascular Interventions. 2010 ; Vol. 3, No. 2. pp. 180-188.
@article{2f4afe68904f4065b73f8bbdf3078f6e,
title = "Impact of Multiple and Long Sirolimus-Eluting Stent Implantation on 3-Year Clinical Outcomes in the j-Cypher Registry",
abstract = "Objectives: Our aim was to study the relationships between total stent length (TSL) and long-term clinical outcomes after sirolimus-eluting stent (SES) implantation. Background: SES compared with bare-metal stent use for long lesion treatment is associated with reduced restenosis rates. Methods: Three-year follow-up data were available for 10,773 patients (14,651 lesions) that had been treated with only SES (Cypher, Cordis Corp., Warren, New Jersey) in the j-Cypher registry. Patients and lesions were divided into quartile groups: TSL per patient (Q1: 8 to 23 mm, Q2: 24 to 36 mm, Q3: 37 to 54 mm, Q4: 55 to 293 mm), and TSL per lesion (QA: 8 to 18 mm, QB: 19 to 23 mm, QC: 24 to 33 mm, QD: 34 to 150 mm). Results: In per-lesion data, longer TSL increased target lesion revascularization (TLR) rates but did not increase stent thrombosis rates (p = 0.2324). In per-patient data, the incidences of TLR remarkably increased with increasing TSL. Incidence of composite of death and myocardial infarction also increased with increasing TSL; however, after adjustment for baseline differences, there was no statistical significance. Definite stent thrombosis rate in group Q4 was significantly higher than in other groups, both unadjusted (hazard ratio: 1.770, p = 0.0081) and adjusted (hazard ratio: 1.727, p = 0.0122) for baseline differences. Conclusions: TSL per lesion and patient had significantly impacts on TLR rates. Longer TSL per patient was associated with increased incidence of stent thrombosis through 3 years.",
author = "Shinichi Shirai and Takeshi Kimura and Masakiyo Nobuyoshi and Takeshi Morimoto and Kenji Ando and Yoshimitsu Soga and Kyohei Yamaji and Katsuhiro Kondo and Koyu Sakai and Takeshi Arita and Masahiko Goya and Masashi Iwabuchi and Hiroyoshi Yokoi and Hideyuki Nosaka and Kazuaki Mitsudo",
year = "2010",
month = "2",
day = "1",
doi = "10.1016/j.jcin.2009.11.009",
language = "English",
volume = "3",
pages = "180--188",
journal = "JACC: Cardiovascular Interventions",
issn = "1936-8798",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Impact of Multiple and Long Sirolimus-Eluting Stent Implantation on 3-Year Clinical Outcomes in the j-Cypher Registry

AU - Shirai, Shinichi

AU - Kimura, Takeshi

AU - Nobuyoshi, Masakiyo

AU - Morimoto, Takeshi

AU - Ando, Kenji

AU - Soga, Yoshimitsu

AU - Yamaji, Kyohei

AU - Kondo, Katsuhiro

AU - Sakai, Koyu

AU - Arita, Takeshi

AU - Goya, Masahiko

AU - Iwabuchi, Masashi

AU - Yokoi, Hiroyoshi

AU - Nosaka, Hideyuki

AU - Mitsudo, Kazuaki

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Objectives: Our aim was to study the relationships between total stent length (TSL) and long-term clinical outcomes after sirolimus-eluting stent (SES) implantation. Background: SES compared with bare-metal stent use for long lesion treatment is associated with reduced restenosis rates. Methods: Three-year follow-up data were available for 10,773 patients (14,651 lesions) that had been treated with only SES (Cypher, Cordis Corp., Warren, New Jersey) in the j-Cypher registry. Patients and lesions were divided into quartile groups: TSL per patient (Q1: 8 to 23 mm, Q2: 24 to 36 mm, Q3: 37 to 54 mm, Q4: 55 to 293 mm), and TSL per lesion (QA: 8 to 18 mm, QB: 19 to 23 mm, QC: 24 to 33 mm, QD: 34 to 150 mm). Results: In per-lesion data, longer TSL increased target lesion revascularization (TLR) rates but did not increase stent thrombosis rates (p = 0.2324). In per-patient data, the incidences of TLR remarkably increased with increasing TSL. Incidence of composite of death and myocardial infarction also increased with increasing TSL; however, after adjustment for baseline differences, there was no statistical significance. Definite stent thrombosis rate in group Q4 was significantly higher than in other groups, both unadjusted (hazard ratio: 1.770, p = 0.0081) and adjusted (hazard ratio: 1.727, p = 0.0122) for baseline differences. Conclusions: TSL per lesion and patient had significantly impacts on TLR rates. Longer TSL per patient was associated with increased incidence of stent thrombosis through 3 years.

AB - Objectives: Our aim was to study the relationships between total stent length (TSL) and long-term clinical outcomes after sirolimus-eluting stent (SES) implantation. Background: SES compared with bare-metal stent use for long lesion treatment is associated with reduced restenosis rates. Methods: Three-year follow-up data were available for 10,773 patients (14,651 lesions) that had been treated with only SES (Cypher, Cordis Corp., Warren, New Jersey) in the j-Cypher registry. Patients and lesions were divided into quartile groups: TSL per patient (Q1: 8 to 23 mm, Q2: 24 to 36 mm, Q3: 37 to 54 mm, Q4: 55 to 293 mm), and TSL per lesion (QA: 8 to 18 mm, QB: 19 to 23 mm, QC: 24 to 33 mm, QD: 34 to 150 mm). Results: In per-lesion data, longer TSL increased target lesion revascularization (TLR) rates but did not increase stent thrombosis rates (p = 0.2324). In per-patient data, the incidences of TLR remarkably increased with increasing TSL. Incidence of composite of death and myocardial infarction also increased with increasing TSL; however, after adjustment for baseline differences, there was no statistical significance. Definite stent thrombosis rate in group Q4 was significantly higher than in other groups, both unadjusted (hazard ratio: 1.770, p = 0.0081) and adjusted (hazard ratio: 1.727, p = 0.0122) for baseline differences. Conclusions: TSL per lesion and patient had significantly impacts on TLR rates. Longer TSL per patient was associated with increased incidence of stent thrombosis through 3 years.

UR - http://www.scopus.com/inward/record.url?scp=76449085829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76449085829&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2009.11.009

DO - 10.1016/j.jcin.2009.11.009

M3 - Article

VL - 3

SP - 180

EP - 188

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

SN - 1936-8798

IS - 2

ER -